From: An insertion variant of MGMT disrupts a STAT1 binding site and confers susceptibility to glioma
Variants | Genotypea | Patients (n = 402) No. (%) | Controls (n = 654) No. (%) | ORb (95 %CI) | P |
---|---|---|---|---|---|
rs11016798 | CC | 135 (34.61) | 186 (29.02) | 1.00 (reference) | Â |
CT | 201 (51.54) | 318 (49.61) | 0.90 (0.68–1.21) | 0.491 | |
TT | 54 (13.85) | 137 (21.37) | 0.57 (0.39–0.85) | 0.006 | |
TT vs. CC + CT |  |  | 0.61 (0.43–0.86) | 0.005 | |
rs487120 | TT | 152 (38.00) | 265 (40.65) | 1.00 (reference) | Â |
CT | 190 (47.50) | 294 (45.09) | 1.13 (0.86–1.49) | 0.385 | |
CC | 58 (14.50) | 93 (14.26) | 1.05 (0.71–1.56) | 0.808 | |
rs557311 | GG | 167 (41.75) | 309 (47.61) | 1.00 (reference) | Â |
AG | 185 (46.25) | 266 (40.99) | 1.28 (0.98–1.68) | 0.072 | |
AA | 48 (12.00) | 74 (11.40) | 1.13 (0.74–1.73) | 0.580 | |
rs1711654 | TT | 190 (47.62) | 325 (50.31) | 1.00 (reference) | Â |
CT | 169 (42.36) | 251 (38.85) | 1.17 (0.89–1.53) | 0.268 | |
CC | 40 (10.02) | 70 (10.84) | 1.01 (0.65–1.57) | 0.963 |